Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

ClinicalTrials.gov ID: NCT00096720

Public ClinicalTrials.gov record NCT00096720. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 11:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Investigating Effects of Short-term Treatment With Pramipexole or Levodopa on [123I]B-CIT and SPECT Imaging in Early Parkinson's

Study identification

NCT ID
NCT00096720
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Institute for Neurodegenerative Disorders
Other
Enrollment
112 participants

Conditions and interventions

Interventions

  • levodopa Drug
  • Mirapex (pramipexole) Drug
  • [123I]ß-CIT and SPECT imaging Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2004
Primary completion
Not listed
Completion
Apr 30, 2007
Last update posted
Sep 28, 2010

2004 – 2007

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Pacific Neuroscience Medical Group Oxnard California 93030
Colorado Neurology, PC Englewood Colorado 80113
Institute for Neurodegenerative Disorders New Haven Connecticut 06510
University of Florida Movement Disorders Center Gainesville Florida 32610
Northwestern University Chicago Illinois 60611
RUSH University Medical Center Chicago Illinois 60612
Boston University Medical Center Boston Massachusetts 02118
Lahey Clinic Medical Center Burlington Massachusetts 01805
Parkinson's Disease and Movement Disorders Center of Albany Medical College Albany New York 12205
Duke University Durham North Carolina 27705
University of Pennsylvania Philadelphia Pennsylvania 19107
NeuroHealth, Inc. Warwick Rhode Island 02886
University of Tennessee Health Science Center Memphis Tennessee 38163

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00096720, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 28, 2010 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00096720 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →